RxHealth Value Will Participate In HHS Pricing Conference; PhRMA Declines
RxHealth Value Executive Director John Golenski, PhD, will be among participants in the Aug. 8-9 HHS pharmaceutical pricing conference.
You may also be interested in...
The pharmaceutical industry's methods for arriving at drug prices will be considered at an HHS conference in August.
The RxHealth Value consumer/payor coalition plans to issue a report on the impact of patent extensions on the pharmaceutical market by this summer.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011